NATCO Pharma Limited (NATCOPHARM.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 179.42B |
| Enterprise Value | 184.57B |
| P/E Ratio | 11.39 |
| PEG Ratio | -0.46 |
| Price/Sales Ratio | 3.96 |
| Price/Book Ratio | 1.75 |
| Enterprise/Revenue | 4.09 |
| Enterprise/EBITDA | 9.61 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.35 |
| Operating Margin | 0.3 |
AD
Management Effectiveness
| Return On Assets | 0.13 |
| Return On Equity | 0.17 |
Income Statement
| Revenue | 40.78B |
| Revenue/Share | 227.74 |
| Gross Profit | 33.88B |
| EBITDA | 17.34B |
| Net Income | 14.19B |
| Diluted EPS | 79.21 |
Balance Sheet
| Total Cash | 28.71B |
| Total Cash/Share | 160.32 |
| Total Debt | 7.14B |
| Total Debt/Equity | 0.08 |
| Current Ratio | 3.01 |
| Book Value Per Share | 514.92 |
Price History
| 52-Week Change | 3.76 |
| 52-Week High | 1,226.8 |
| 52-Week Low | 789 |
| Moving Average 50 Days | 1,051.56 |
| Moving Average 200 Days | 930.56 |
Statistics
| Average Volume | 871,049 |
| Shares Outstanding | 179.11M |
| % Held by Institutions | 0.05 |
Dividend And Splits
| Trailing Annual Dividend Rate | 5 |
| Trailing Annual Dividend Yield | 0.55 |
| Payout Ratio | 0.03 |
| Last Split Factor | 5:1 |
| Last Split Date | November 26, 2015 |
AD
